Open-House Biologics Discount Agreements 2026-13 - Romiplostim
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-13 - Romiplostim
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
15 / 100
Risk factors
The agreement does not guarantee any sales volume; actual demand depends on prescription behavior and competition from...
This is not a public procurement; legal remedies lie with social courts, not procurement chambers. Different rules appl...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Jun 2028
- Supply of pharmaceutical products containing Romiplostim.
- Conclusion of discount agreements with health insurance funds (Techniker Krankenkasse, HEK, hkk).
Show full summary
This is an Open-House procedure to conclude discount agreements (Rabattverträge) for the active substance Romiplostim under §130a SGB V. All eligible pharmaceutical entrepreneurs can join at any time during the contract period (up to 24 months). No exclusivity is granted, and no guaranteed volume. The procedure is not a public procurement according to EU directives; legal disputes go to social courts.
Risks
The agreement does not guarantee any sales volume; actual demand depends on prescription behavior and competition from...
This is not a public procurement; legal remedies lie with social courts, not procurement chambers. Different rules appl...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur within the meaning of §4(18) AMG with valid marketing authorization for Romiplostim.
- Must have seat in Germany, EU, or EEA.
Administrative
- Must submit a self-declaration on admission and reliability (Anlage 4).
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House Biologics Discount Agreements 2026-13 - Romiplostim
Conclusion of drug discount agreements for Romiplostim with eligible pharmaceutical entrepreneurs under an Open-House procedure.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Romiplostim im Rahmen eines Open-House-Verfahrens.
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2026-13 - Romiplostim
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Romiplostim im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 07 May 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 318965-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
15 / 100
Risk factors
The agreement does not guarantee any sales volume; actual demand depends on prescription behavior and competition from...
This is not a public procurement; legal remedies lie with social courts, not procurement chambers. Different rules appl...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications